Respiratory Distress Syndrome, Newborn: all 1,179 studies
Page 7 of 12. Open to participants first (160), then studies with results posted, then the rest; newest registration first within each.
- Prono Position and Mechanical PowerCompletedNCT04369105
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 InfectionNo longer availableNCT04366830
- Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeStatus unknownNCT04366063Phase 2/3
- Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory DistressCompletedNCT04363463Not applicable
- Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 InfectionStatus unknownNCT04361903
- Pilot Study on Cytokine Filtration in COVID-19 ARDSStatus unknownNCT04361526Not applicable
- Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19TerminatedNCT04360096Phase 2/3
- Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 InfectionTerminatedNCT04359862Phase 4
- Different PEEP Settings of COVID-19 Induced ARDSCompletedNCT04359251Not applicable
- Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.Status unknownNCT04359134
- Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 PatientsStatus unknownNCT04358627
- Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19CompletedNCT04357444Phase 2
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)TerminatedNCT04355364Phase 3
- Effect of PEEP Titration on the EELV Measured by the Nitrogen Dilution Technique in ARDSStatus unknownNCT04352725Not applicable
- Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress SyndromeCompletedNCT04351906Not applicable
- Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDSStatus unknownNCT04350710
- Polyvalent Immunoglobulin in COVID-19 Related ARdsCompletedNCT04350580Phase 3
- BAttLe Against COVID-19 Using MesenchYmal Stromal CellsSuspendedNCT04348461Phase 2
- Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19TerminatedNCT04347980Phase 3
- Spironolactone in Covid-19 Induced ARDSCompletedNCT04345887
- Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19CompletedNCT04343404
- Hemodynamic Characteristics of Patients With SARS-CoV-2CompletedNCT04337983
- Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)Status unknownNCT04337190
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4
- LIBERATE Trial in COVID-19WithdrawnNCT04334629Phase 4
- Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm InfantsCompletedNCT04333563Not applicable
- Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDSCompletedNCT04333368Phase 1/2
- Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDSStatus unknownNCT04331613Phase 1/2
- Lung Ultrasound to Guide Surfactant TherapyCompletedNCT04330443Not applicable
- COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil IIITerminatedNCT04327401Phase 3
- The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated PneumoniaCompletedNCT04325685Not applicable
- Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19TerminatedNCT04325061Phase 4
- Neonatal Cardio-Pulmonary Outcome MeasureCompletedNCT04324957
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
- Complications Related to Transpulmonary ThermodilutionStatus unknownNCT04319965
- Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]Status unknownNCT04317469
- Surfactant Nebulization for the Early Aeration of the Preterm LungCompletedNCT04315636Phase 3
- A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP CircuitsCompletedNCT04311320Not applicable
- Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress SyndromeCompletedNCT04289194Phase 1/2
- Prone Position and Renal Resistive IndexCompletedNCT04286490Not applicable
- Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDSCompletedNCT04247477Not applicable
- Feasibility of Uninterrupted Infant Respiratory Support TreatmentCompletedNCT04244890
- PEEP and Spontaneous Breathing During ARDSCompletedNCT04241874Not applicable
- High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure for Respiratory Support of Preterm NeonatesCompletedNCT04238273
- Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With ARDS (PReSPON)Status unknownNCT04228471Not applicable
- Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome PatientsCompletedNCT04219150Not applicable
- Breathing Pattern, WOB and Gas Exchange in Patients With Acute Respiratory Distress Syndrome During the Spontaneous Breathing TrialStatus unknownNCT04209270
- Telemedicine in the Generals Practitioners OfficeStatus unknownNCT04168554
- The Role of Morphological Phenotype in ARDSCompletedNCT04157946
- Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress SyndromeCompletedNCT04156438Not applicable
- Acute Kidney Injury in Patients With Acute Respiratory Distress SyndromeCompletedNCT04154007
- Early Use of Prone Position in ECMO for Severe ARDSCompletedNCT04139733
- Pulmonary Microbiota and ARDS MortalityStatus unknownNCT04133558
- LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm InfantsStatus unknownNCT04126382Phase 2
- Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature NeonatesStatus unknownNCT04118400
- Decision Support System to Evaluate VENTilation in ARDSCompletedNCT04115709Not applicable
- Role of Lung Ultrasound In Assessment Of Recruitment Maneuvers In Ventilated Preterms With Respiratory Distress Syndrome and Its Correlation With Tracheal IL-6 LevelCompletedNCT04107090Not applicable
- Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory DetresseCompletedNCT04106128Not applicable
- A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)TerminatedNCT04096235Not applicable
- Feasibility Study - NeofactCompletedNCT04086095Not applicable
- Postoperative Respiratory AbnormalitiesStatus unknownNCT04079829
- Tetracycline to Limit the Innate Immune Response in Acute Respiratory Distress SyndromeStatus unknownNCT04079426
- Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.Status unknownNCT04073173Phase 4
- Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) PathwayCompletedNCT04070053Not applicable
- Pediatric Acute Respiratory Distress Syndrome Asia StudyCompletedNCT04068038
- A Comparative Study Between Postextubation of Preterm Infants Into High-Flow Nasal Cannulae V.S Nasal Continuous Positive Airway PressureCompletedNCT04051762
- A Modified Mathematical Model to Calculate Power Received by Mechanically Ventilated Patients With Different EtiologiesStatus unknownNCT04046380
- Caffeine Treatment in in the Delivery RoomCompletedNCT04044976Not applicable
- The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?TerminatedNCT04028336Not applicable
- Sevoflurane PharmacokInetics in ARDSTerminatedNCT04023305Not applicable
- Impact of Neurophysiological Facilitation of Respiration in Preterm NeonatesStatus unknownNCT04019886Not applicable
- Budesonide With Intratracheal Surfactants in Extremely Preterm InfantsStatus unknownNCT04019106Phase 1/2
- Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome CourseStatus unknownNCT04014218Phase 4
- Breathing Variability and NAVA in NeonatesCompletedNCT04000568
- Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing AbnormalitiesWithdrawnNCT03996317Not applicable
- Modified Intubation-surfactant-extubation (InSurE) Technique in Preterm Neonates With Respiratory Distress SyndromeStatus unknownNCT03989960Not applicable
- Clinical Decision Support for Mechanical Ventilation of Patients With ARDSStatus unknownNCT03984175Not applicable
- The Value of Combined Critical Care Ultrasound and PAC Monitor Oriented Therapy Protocol to Patients of ARDS With ACPStatus unknownNCT03971331Not applicable
- Immune Alveolar Alterations During Pneumonia-Associated Acute Respiratory Distress SyndromeStatus unknownNCT03971006
- PEEP-induced Changed in RRI as Physiological Background of Ventilator-induced Kidney InjuryCompletedNCT03969914
- Determination of the Best Positive End-expiratory Pressure (PEEP)CompletedNCT03969407
- Comparison of the PaO2/FiO2 Ratio to Other Oxygenation Indexes for the Classification of Severity of Acute Respiratory Distress SyndromeCompletedNCT03946189
- PaO2/FiO2*PEEP (P/FP) Ratio and Mortality in Acute Respiratory Distress Syndrome.CompletedNCT03946150
- Feasibility and Impact of Volume Targeted Ventilation in the Delivery RoomTerminatedNCT03938532Not applicable
- Echocardiographic Evaluation in ARDS PatientsCompletedNCT03920189
- Pragmatic Investigation of Volume Targeted Ventilation-1CompletedNCT03909854Not applicable
- Hemodynamic Effects of PEEP in ARDSStatus unknownNCT03896802Not applicable
- Hemoglobin Concentration in Patients With an Acute Respiratory Distress SyndromeCompletedNCT03871166
- Surfactant Administration Via Thin Catheter Using a Specially Adapted Video LaryngoscopeStatus unknownNCT03846960Not applicable
- Macrophage Programing in Acute Lung InjuryStatus unknownNCT03844893
- NHFOV vs NIPPV vs nCPAP in Preterm Infants With Respiratory Distress SyndromeStatus unknownNCT03842462Not applicable
- Lung Ultrasound to Detect Pulmonary Complications in Critically Ill ParturientsCompletedNCT03828630
- Acute CorPulmonale and ARDS Circulation Protection China Study China (ACPC)Status unknownNCT03827863
- Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress SyndromeCompletedNCT03807804Phase 2
- Peer Support for Post Intensive Care Syndrome Self-ManagementStatus unknownNCT03788096Not applicable
- Automatic Oxygen Control (SPOC) in Preterm InfantsStatus unknownNCT03785899Not applicable
- Ventilatory Monitoring in Children With Respiratory Distress Syndrome With Electrical Impedance TomographyCompletedNCT03768921Not applicable
- Ventilator Induced Diaphragm Dysfunction in Pediatric Critically Ill Patients (VIDD)Status unknownNCT03768232
- The Role of Circulating CircRNAs and MicroRNAs in Acute Lung InjuryStatus unknownNCT03766204